Aurobindo Pharma Ltd Buyback
Aurobindo Pharma Buyback 2024
Tender Offer
₹1,460.00
Buyback price per shareAbout Aurobindo Pharma Ltd Buyback
Aurobindo Pharma is a manufacturer of active pharmaceutical ingredients (API) and formulation products in Pondicherry.
The company manufactures semi-synthetic penicillin (SSP), neuroscience (CNS), cardiovascular (CVS), antiretrovirals, antidiabetics, gastroenterology and antibiotics.
Aurobindo has a multi-product portfolio with manufacturing facilities in several countries. The company generated revenues of USD 2.6 billion in the financial year 2017-18. Aurobindo's 11 API/intermediates units and 15 formulations units (10 in India, 3 in the US, 1 in Brazil and 1 in Portugal) are designed to cater to the needs of both advanced and emerging markets.
Aurobindo Pharma Ltd Buyback Details
Security Name
Aurobindo Pharma LtdBuyback Price
₹1,460.00Face Value
₹1.00Listing at Group
BSE, NSELead Manager
Axis Capital LimitedBuyback Docs
Letter Of OfferIssue Size
51,36,986 ( 0.88% of Total number of equity Shares)Aurobindo Pharma Buyback 2024 Issue Timetable
| Last Date to buy shares | Record Date | Offer Opens On | Offer Closes On * |
| Jul 29, 2024 | Jul 30, 2024 | Aug 5, 2024 | Aug 9, 2024 |
| Last Date for receipt of Tender Forms | Finalisation of Buyback Acceptance | Last Date for settlement of bids | Last Date for Extinguishment of Shares |
| Aug 9, 2024 | Aug 16, 2024 | Aug 19, 2024 | Aug 28, 2024 |
Aurobindo Pharma Ltd Buyback Ratio
| Category | Entitlement Ratio of Buyback | Shares Offered |
| Reserved Category for Small Shareholders | 5/41 | 770548 |
| General Category for all other Eligible Shareholders | 4/531 | 4366438 |
Company Financials All values are in ₹ Cr.
| Period Ended | 31-Mar-24 | 31-Mar-23 | 31-Mar-22 |
|---|---|---|---|
| Total Borrowing | -- | -- | -- |
| Profit After Tax | 195.41 | 122.71 | -- |
| Total Revenue | 1,126.17 | 890.09 | -- |
| Reserves And Surplus | -- | -- | -- |
| Net Worth | -- | -- | -- |
| Total Assets | 2,515.40 | 2,505.88 | -- |
How to Participate in Aurobindo Pharma Ltd Buyback?
1. Firstly, to be eligible for the buyback the investor should have shares of Aurobindo Pharma Ltd Buyback in Demat or physical form as on the record date Jul 30, 2024.
2. Once you have shares in Demat, you can participate in the buyback process which is opening from Aug 5, 2024 by selling your shares through your broker on BSE, NSE.
3. Then on Aug 28, 2024, the payment will be given to you for accepted shares and unaccepted shares will be returned to your Demat account.
Calculation of Investment in Aurobindo Pharma Ltd Buyback
Maximum market value of a share holder as on record date | ₹200,000.00 |
Buyback price per share | ₹1,460.00 |
Maximum share for small shareholders (200000/ 1460) | 136.99 share |
Closing price of stock as of 2024-07-16 | ₹1,371.05 |
Maximum amount insted in buyback (₹1,371.05 x 136.986301369863 shares) | ₹187,815.07 |
* No. of shares stands to change according to the closing price on the record date
* For simplicity, we have considered the price on date Jul 16, 2024
Expected Profit from the Aurobindo Pharma Ltd Buyback on the bases of acceptance Ratio:
Acceptance Ratio | 33% | 50% | 75% | 100% |
Amount Invested in Buyback | ₹187,815.07 | ₹187,815.07 | ₹187,815.07 | ₹187,815.07 |
No. of Shares Buyback | 45 | 68 | 102 | 136 |
Buyback Profit | 4002 | 6048 | 9072 | 12097 |
Profit% | 2.13% | 3.22% | 4.83% | 6.44% |
Aurobindo Pharma Ltd Buyback - Necessity of the Objective
The buy-back will help the company reward its shareholders and enhance the overall return to shareholders.
The buy-back is expected to improve earnings per share and other key ratios such as return on net worth and return on assets over a period of time.
The buy-back is being implemented through the tender offer route as prescribed under the buyback regulations and would involve the allocation of the number of equity shares as per their entitlement or 15% of the number of equity shares to be bought back, whichever is higher, reserved for small shareholders.
Aurobindo Pharma Ltd Buyback
Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032Email: info@aurobindo.com
Phone: +91 40 6672 5000
Website: http://www.aurobindo.com/
Kfin Technologies Limited
Email: aurobindo.buyback@kfintech.com
Phone: 04067162222, 04079611000
Website: https://kosmic.kfintech.com/ipostatus/
